논문번호 | 71 | ||
논문제목(영문) | Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry. | ||
국내외구분 | 국외 | SCI여부 | SCI(E) |
연구책임자역할 | 교신저자 | ||
주저자명 | Lee SR | ||
교신저자명 | Jeong MH | ||
공동저자명 | Lee SR, Jeong MH, Ahn YK, Chae SC, Hur SH, Kim YJ, Seong IW, Chae JK, Hong TJ, Rhew JY, Cho MC, Bae JH, Rha SW, Kim CJ, Jang YS, Park SJ; | ||
게제년월일 | 2007-11-01 | ||
ISSN | 1346-9843 | ||
Impact Factor | 3.940 | ||
학술지명 | Circulation journal | ||
서지사항 | 0집 / 72권 / 3호, 페이지(392 - 398) | ||
요약초록문 (Abstract) 입력 |
BACKGROUND: Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) may be useful in patients with acute myocardial infarction (AMI), but safety issues still need to be solved. This study was undertaken to investigate the incidence of major adverse cardiac events (MACE) and stent thrombosis in DES-implanted AMI patients in real-life clinical practice. METHODS AND RESULTS: On-line registry of AMI cases at the web site www.kamir.or.kr has been performed in 41 primary PCI centers in Korea and between November 2005 and September 2006, 1,541 surviving patients who had been implanted with either Cypher or Taxus stents were enrolled for analysis during a 6-month clinical follow-up. There were 2 groups: group I [834 patients, 61.9+/-11.9 years: sirolimus-eluting stent (Cypher)], group II [707 patients, 62.9+/-12.0 years: paclitaxel-eluting stent (Taxus)]. At both 1 and 6 months the incidence of MACE was not significantly different between the 2 groups. There were 17 cases of stent thrombosis, but the incidence of stent thrombosis was not significantly different between the 2 groups (group I:II=9 (1.1%):8 (1.1%), p=1.000). The stent type, length, number, lesion complexity and diabetes were not significant for the incidence of MACE or stent thrombosis after adjustment. CONCLUSION: MACE and stent thrombosis rates did not differ between 2 types of DES identified in Korea Acute Myocardial Infarction Registry (KAMIR). DES can be used in patients with AMI with a relatively low 6-month MACE rate. |
||
파일 |
C71.+Circ+J.+2008;72(3)392-398..pdf (76.5K) DATE : 2021-05-21 16:53:37 |
전라남도 장성군 남면 삼태리 산 109 나노바이오연구원 3층 306호 TEL : 061-392-6243 Fax: 061-392-6243
Copyright ⓒ 2014 Korea Cardiovascular Stent Research Institute. All right Reserved